Mirae Asset Global Investments Co., Ltd. Adaptive Biotechnologies Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,869 shares of ADPT stock, worth $101,357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,869
Previous 4,938
18.85%
Holding current value
$101,357
Previous $36,000
88.89%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ADPT
# of Institutions
265Shares Held
149MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$518 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$195 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$108 Million1.68% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.3MShares$74.3 Million0.03% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.47B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...